Lymphocytic colitis: a clue to bacterial etiology.

Department of Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
World Journal of Gastroenterology (Impact Factor: 2.43). 01/2006; 11(46):7266-71.
Source: PubMed

ABSTRACT To find out the role of bacteria as a possible etiological factor in lymphocytic colitis.
Twenty patients with histopathological diagnosis of lymphocytic colitis and 10 normal controls were included in this study. Colonoscopic biopsies were obtained from three sites (hepatic and splenic flexures and rectosigmoid region). Each biopsy was divided into two parts. A fresh part was incubated on special cultures for bacterial growth. The other part was used for the preparation of histologic tissue sections that were examined for the presence of bacteria with the help of Giemsa stain.
Culture of tissue biopsies revealed bacterial growth in 18 out of 20 patients with lymphocytic colitis mostly Escherichia coli (14/18), which was found in all rectosigmoid specimens (14/14), but only in 8/14 and 6/14 of splenic and hepatic flexure specimens respectively. In two of these cases, E coli was associated with proteus. Proteus was found only in one case, Klebsiella in two cases, and Staphylococcus aureus in one case. In the control group, only 2 out of 10 controls showed the growth of E coli in their biopsy cultures. Histopathology showed rod-shaped bacilli in the tissue sections of 12 out of 14 cases with positive E coli in their specimen's culture. None of the controls showed these bacteria in histopathological sections.
This preliminary study reports an association between E coli and lymphocytic colitis, based on histological and culture observations. Serotyping and molecular studies are in process to assess the role of E coli in the pathogenesis of lymphocytic colitis.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The cells that line the mucosa of the human gastrointestinal tract (GI, that is, oral cavity, oesophagus, stomach, small intestine, large intestine, and rectum) are constantly challenged by adverse micro-environmental factors, such as different pH, enzymes, and bacterial flora. With exception of the oral cavity, these microenvironments also contain remnant cocktails of secreted enzymes and bacteria from upper organs along the tract. The density of the GI bacteria varies, from 103/mL near the gastric outlet, to 1010/mL at the ileocecal valve, to 1011 to 1012/mL in the colon. The total microbial population (ca. 1014) exceeds the total number of cells in the tract. It is, therefore, remarkable that despite the prima facie inauspicious mixture of harmful secretions and bacteria, the normal GI mucosa retains a healthy state of cell renewal. To counteract the hostile microenvironment, the GI epithelia react by speeding cell exfoliation (the GI mucosa has a turnover time of two to three days), by increasing peristalsis, by eliminating bacteria through secretion of plasma cell-immunoglobulins and by increasing production of natural antibacterial compounds, such as defensin-5 and lysozyme. Only recently, lysozyme was found up-regulated in Barrett's oesophagitis, chronic gastritis, gluten-induced atrophic duodenitis (coeliac disease), collagenous colitis, lymphocytic colitis, and Crohn's colitis. This up-regulation is a response directed to the special types of bacteria recently detected in these diseases. The aim of lysozyme up-regulation is to protect individual mucosal segments to chronic inflammation. The molecular mechanisms connected to the crosstalk between the intraluminal bacterial flora and the production of lysozyme released by the GI mucosae, are discussed. Bacterial resistance continues to exhaust our supply of commercial antibiotics. The potential use of lysozyme to treat infectious diseases is receiving much attention.
    03/2014; 3(1):73-92. DOI:10.3390/pathogens3010073
  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE:: To study Microscopic Colitis (MC) in children with special reference to its role in chronic diarrhea and changes in mucosal biopsies. METHODS:: 100 consecutive children aged 3-12 years, with non-bloody diarrhea (passage of ≥ 3 loose stools/ day) of >12 weeks duration were screened and 26 were enrolled in the study where no specific etiology could be found and colonoscopy did not reveal any mucosal abnormality. Colonic biopsies were evaluated for the presence of lymphocytic colitis (LC) or collagenous colitis (CC) and those with the characteristic changes were defined to have MC [group A]. Colonic biopsies from patients with MC were compared with biopsies from patients with chronic diarrhea but no evidence of MC [group B].100 children aged 3-12 years with bleeding per rectum were screened and colonic biopsies from 45 patients [group C] who had colonic mucosal changes but no vascular or polyp lesion were compared with patients with MC. RESULTS:: Of the 26 chronic diarrhea patients, MC was found in 5 (3 LC and 2 CC). Significantly higher polymorphonuclear infiltration was seen in group A as compared to group B [13.8(5.4-20.6) vs. 7.2(0-19.6), p value- 0.03] or group C [13.8(5.4-20.6) vs. 4(0-13.4), p value-0.007]. Intra-epithelial lymphocytes [12(4-32) vs. 4(0-24), p value-0.008] and basement membrane thickening [3.5(2.9-10.6) vs. 2.5(1.6-5.86), p value-0.008] were also significantly higher in group A as compared to group C. CONCLUSION:: MC was found to be present in children with non-bloody chronic diarrhea in children. Further multi-centric studies may provide adequate data on its prevalence.
    Journal of pediatric gastroenterology and nutrition 04/2013; DOI:10.1097/MPG.0b013e3182942868 · 2.87 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Regulatory T cells (Tregs) are specialized CD4(+) T lymphocytes helping defend against autoimmunity and inflammation. Although age is associated with increased inflammation and autoimmunity, few reports address age effects of immune regulation or auto-aggressive T cells. We show here that young and aged naïve CD4(+) T cells are equivalently auto-aggressive in vivo in T cell-driven autoimmune colitis. Young and aged CD4(+) Tregs equally suppressed age-matched T cell proliferation in vitro and controlled clinical and pathologic T cell-driven autoimmune colitis, suggesting equivalent regulatory function. However, whereas young and aged CD4(+) Tregs suppressed interferon (IFN)-γ(+) T cells equivalently in this model, aged CD4(+) Tregs unexpectedly failed to restrain interleukin (IL)-17(+) T cells. Nonetheless, young and aged CD4(+) Tregs equally restrained IL-17(+) T cells in vivo during acute inflammation, suggesting a chronic inflammation-related defect in aged CD4(+) Tregs. In support, aged Tregs expressed reduced STAT3 activation, a defect associated with poor IL-17-producing T cell restraint. Aged naïve mice had markedly increased programmed death (PD)-1(+) T cells, but these exhibited no significant auto-aggressive or regulatory functions in T cell-driven colitis. Young CD8(+)  CD122(-) T cells induce autoimmune bone marrow failure, but we show that aged CD8(+)  CD122(-) T cells do not. These data demonstrate no apparent age-related increase in auto-aggressive T cell behavior, but disclose previously unrecognized functional defects in aged CD4(+) Tregs during chronic inflammation. IL-17 can be inflammatory and contributes to certain autoimmune disorders. Reduced aged Treg function during chronic inflammation and reduced IL-17 restraint could contribute to age-related inflammation or autoimmunity.
    Aging cell 02/2012; 11(3):509-19. DOI:10.1111/j.1474-9726.2012.00812.x · 5.94 Impact Factor


Available from